IL1B and chronic kidney disease: Treatment with an IκB kinase inhibitor attenuated sepsis-induced cardiac dysfunction with chronic kidney disease (CKD) via reduced expression of inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-10) (Chen et al., 2017).